All posts by PE Podcasts

Setti Coscarella on the Better Way to Smoke | #HashtagFinance

CSE’s Phillip Shum chats with TAAT Lifestyle & Wellness Ltd. (CSE:TAAT) CEO Setti Coscarella about their objective to introduce an innovative, experience-driven alternative to tobacco cigarettes for tobacco smokers who aspire to leave nicotine behind.

Here’s an overview of what they cover in this episode of #HashtagFinance:

0:35 – Introducing Setti and the TAAT mission
1:57 – Setti’s background with Phillip Morris’ heat – not burn – product (IQOS)
4:15 – How Hemp/CBD cigarettes emulate a tobacco/nicotine smoke
7:43 – Manufacturing and marketing differences between hemp and tobacco cigarettes
11:53 – Recently secured manufacturing partner and patent filing
14:42 – Where TAAT is currently being sold and tested
16:37 – What you didn’t know about the tobacco industry
18:35 – Setti’s goals as the new CEO of TAAT
19:45 – TAAT’s opportunity in the 900Bn global tobacco market

Related links
https://thecse.com/en/listings/life-sciences/taat-lifestyle-wellness-ltd
https://taatusa.com/ 

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Anthony Brown on Computing the New Digital Era | #HashtagFinance

CSE’s Anil Mall chats with Anthony Brown, CEO of AMPD Ventures Inc. (CSE:AMPD), about his company’s ambitions in providing high-performance cloud and computing solutions for low-latency applications, including video games and eSports, digital animation and visual effects, and big data collection, analysis and visualization.

Here’s an overview of what Anil and Anthony cover in this edition of the #HashtagFinance podcast:

0:35 – Catching-up with AMPD CEO Anthony Brown.
3:10 – What does it mean to be a “Next Generation Digital Infrastructure” company?
4:45 – High Performance Computing vs Commodity Computing.
6:00 – The potential of the global eSports, virtual reality, and digital effects sectors.
8:55 – Recent announcements re: AccelByte and Versatile Media.
13:06 – The financial impact on the film and television industry.
16:15 – Being the company that provides the picks and shovels for the gold rush of virtual production.
20:15 – The Supercluster Project w/ an airline manufacturing plant.
24:20 – How Anthony’s passion comes from his 30 years of experience in the industry.
27:15 – What Stephen Hynes brings to the AMPD team.
30:15 – The Waterfall Building and how it illustrates urban efficiency.
33:35 – Outlook for the remainder of the year.
35:35 – The coming Virtual Reality metaverse aka Ready Player One.

Related links
https://thecse.com/en/listings/technology/ampd-ventures-inc 
https://ampd.tech 

A legal disclaimer for AMPD Ventures Inc. can be found here: https://ampd.tech/legal/general-disclaimer/

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Making Sense of Today’s US Markets with Richard Carleton & Jason Paltrowitz | AFTER MARKET SPECIAL

Curious about what’s happening in the US stock market? We invited two market experts to discuss the recent rally in the US on our AFTER MARKET programs and compiled both interviews for your listening pleasure.

Firstly, JB & Bear are joined by their third ever guest on AFTER MARKET – Richard Carleton, CEO of the CSE – Canadian Securities Exchange. In this “After Hours” segment we tap the expert to better understand the recent stock market rally in the face of the global pandemic.

Here’s a highlight of everything discussed on this podcast:

0:35 – Introducing Richard Carleton, CEO of the Canadian Securities Exchange
2:35 – Understanding performance attribution within indices
5:00 – What happens to the stock market when things go back to “normal”?
7:05 – Investing FOMO and behavioural economics
11:20 – Why it’s hard to beat ETF and Mutual Fund returns (but the lizard brain doesn’t care)
13:55 – Money is effectively “free” – how does this impact the equity markets? (Warning: inflation alert!)

Following Richard’s interview, JB & Bear are joined by their fourth guest on AFTER MARKET – Jason Paltrowitz, EVP of  @OTC Markets Group In this “After Hours” segment we tap the expert to better understand how the US markets and economy are proving their resiliency in historically difficult conditions.

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Michael Frank on the Race to Fight Infectious Diseases | #HashtagFinance

CSE’s Barrington Miller chats with Michael Frank, CEO of Revive Therapeutics Ltd. (CSE:RVV) about his company’s ambitions to enter Phase 3 clinical trial protocol to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19.

With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury
from organ transplantation.

Related links
https://revivethera.com/
https://thecse.com/en/listings/life-sciences/revive-therapeutics-ltd

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Sue Ozdemir on Delivering “Next Gen” Electric Motors and Powertrains | #HashtagFinance

CSE’s Anil Mall chats with Exro Technologies Inc. (CSE:XRO) CEO, Sue Ozdemir, about their strategy to commercialize its proprietary technology through strategic partnerships for specific near-term market opportunities.

Here’s an overview of what they cover in this podcast:

01:32 – Making electric motors smart with power electronics.
4:12 – A new type of inverter – intelligent coil driver.
5:43 – Positioned in the $100Bn global electric vehicle market.
8:01 – Sue’s background in the electric motor business, including GE Motor Division.
12:10 – Partnership 1 – Potential to retrofit combustion engines with electric engines.
15:23 – Partnership 2 – Clean Seed Capital to co-develop electric seeders.
16:38 – Partnership 3 – Working w/ Zero Motorcycle, the top manufacturer electric motorcycle.
17:11 – Partnership 4 – Sea Electric to develop an electric delivery van and co-developing a garbage truck for NA market.
21:18 – The approach to engaging new partners,

Exro is a Clean Tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced motor control technology, their “Coil Driver”, expands the capabilities of electric motors and powertrains. The Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque, while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real-time so that torque demand and efficiency are optimized.

The limitations of traditional electric machines and power technology are becoming more evident. In many increasingly prominent applications, traditional methods cannot meet the required performance. This means either oversizing the equipment, adding additional motors, or implementing heavy mechanical geared solutions. Exro offers a new solution for system optimization through implementation of its technology which can yield the following results: increased drive cycle efficiency, reduced system volume, reduced weight, expanded torque and speed capabilities. Exro allows the application to achieve more with less energy consumed.

Related links
https://www.exro.com/
https://thecse.com/en/listings/technology/exro-technologies-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Jonathan Buick on Developing a Technical Knockout in Idaho | #HashtagFinance

CSE’s Barrington Miller chats with Jonathan Buick, CEO of Idaho Champion Gold Mines Canada Inc. (CSE:ITKO) about his company’s recently closed $8.1 million bought deal financing and the plans for its two fully funded 2020 exploration programs at its Baner and Champagne Gold Projects located in Idaho, USA.

Idaho Champion is a discovery-focused gold exploration company that is committed to advancing its 100% owned highly prospective mineral properties located in Idaho, United States. The Company’s shares trade on the CSE under the trading symbol “ITKO”. Idaho Champion is vested in Idaho with the Baner Project in Idaho County, the Champagne Project located in Butte County near Arco, and four cobalt properties in Lemhi County in the Idaho Cobalt Belt. Idaho Champion strives to be a responsible environmental steward, stakeholder and a contributing citizen to the local communities where it operates. Idaho Champion takes its social license seriously, employing local community members and service providers at its operations whenever possible.

Related links
https://idahochamp.com/
https://thecse.com/en/listings/mining/idaho-champion-gold-mines-canada-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Dr. Ahmad Doroudian on the Potential of a COVID-19 Treatment | #HashtagFinance

Dr. Ahmad Doroudian on the Potential of a COVID-19 Treatment, Not a Cure | #HashtagFinance

The CSE’s Barrington Miller chats with Dr. Ahmad Doroudian, CEO of BetterLife Pharma Inc. (CSE:BETR), about BetterLife’s ambitions to advance on the AP-003 clinical trial programs of Altum Pharmaceuticals Inc., which includes a therapeutic pipeline consisting of three products, including AP-003, a patent-pending interferon a2b (IFNa2b) inhalation formulation. Recent studies in China and the UK have provided data that suggest the therapeutic efficacy of interferon-based treatments for COVID-19.

Here’s an overview of what’s covered in this edition of the #HashtagFinance podcast:

3:47 – What BetterLife is doing about COVID-19.

7:01 – How early their product can be used, and if it can be used for prevention.

9:32 – What BetterLife was working on before the COVID-19 pandemic.

11:32 – The differentiators between BetterLife and other companies developing COVID-19 treatments.

15:38 – Taking the treatment approach, instead of the cure approach, to COVID-19, similar to HIV.

19:58 – Phase II clinical trials, and what that means for an investor.

BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Through its wholly owned subsidiary, BLife Therapeutics Inc., BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

Related links:

Home

https://thecse.com/en/listings/life-sciences/betterlife-pharma-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Brad Moore on Leveraging Blockchain to Improve Outcomes for Medical Cannabis Patients | #HashtagFinance

CSE’s Barrington Miller chats with Brad Moore, CEO of Global Cannabis Applications Corp. (CSE:APP) about his company’s ambitions as a technology company that strives to improve medical cannabis patients’ outcomes through the gathering and analysis of deep data.

Here’s an overview of what Barrington and Brad cover in this edition of the #HashtagFinance podcast:

1.10 – Virtual work is nothing new for Brad and his international team.
3:35 – GCAC’s Israeli technology connection.
6:01 – How Brad has applied his military mindset into the cannabis/tech industries.
9:53 – The impact of the early 2018 cannabis “craze” on the company.
13:54 – Defining 2020 as the year of the (delayed) balance sheet.
15:46 – The application of blockchain on their business model.
18:20 – Building data points during COVID.
19:35 – The differentiator.
23:53 – The power of data to improve patient incomes.
28:47 – What a potential exit path looks like for the company.

Current approval processes for medical treatments generally start with a formulation of elements. The objective of any clinical study is to ensure efficacy, and safety, within a fixed sampling size. However as cannabis is a plant, and each plant is unique, the challenges have been in ensuring that each gram tested would provide a consistent result. In response to these challenges, GCAC has developed a patent-pending data model called, Seed to Seed.

GCAC’s approach is to measure an individual’s unique treatment experience on a per dosage basis. By digitally measuring both the biometric & anecdotal feedback and comparing that to others using the same or similar products on a large scale, GCAC can provide an averaged efficacy rating for the treatment used. This is accomplished through a proprietary system of mobile applications, heart monitoring biometrics, Artificial Intelligence and machine learning. When integrated with blockchain seed to sale solutions, GCAC technology will be able to recommend “how to treat ailment X with product Y at a given point in time under a set of circumstances”. By securing this information on an EU GDPR complaint blockchain, their data outputs are comparable to results generated by a regulatory approval process.

Related links:
https://thecse.com/en/listings/technology/global-cannabis-applications-corp

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Paul Rosen on the One Non-Negotiable for Success in Cannabis | #HashtagFinance

CSE’s Barrington Miller chats with Paul Rosen, CEO of 1933 Industries Inc. (CSE:TGIF) about his recent appointment as Interim CEO of the company and his operating philosophy moving forward in the face of COVID-19. Paul also shares his personal journey as an early leader in the cannabis industry and makes note of the many changes he’s observed in the C-suite among his cannabis sector peer group.

Here’s an overview of what Barrington and Paul cover in this edition of the #HashtagFinance podcast:

2:00 – Paul’s early beginnings in the Cannabis industry in the late 80’s as a constitutional lawyer.
3:58 – Hortican Inc.’s pre-MMPR history and evolution with PharmaCan Capital Corp./The Chronos Group.
6:57 – His transition into a management role at 1933 Industries.
7:55 – How Cannabis 2.0 has impacted C-suites in the industry.
11:58 – Highlighting traits of the early-stage Cannabis entrepreneurs.
13:28 – The unique challenges of running a public cannabis company.
17:16 – The imperative of running a clean balance sheet in today’s COVID-19 environment.
20:14 – Las Vegas’ cannabis prospects in light of the severe downturn in tourism.
25:25 – Paul’s view on how the global pandemic will hasten tax generation from cannabis and social justice.
29:35 – Why preparing for domestic (US) demand is still the biggest opportunity in cannabis.
31:57 – The shift to prioritizing profitability first.

1933 Industries is a vertically-integrated, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats.

Related Links
https://1933industries.com/
https://thecse.com/en/listings/diversified-industries/1933-industries-inc

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS

Daniel Safayeni on the OCC’s Fight to Save Curbside Cannabis | #HashtagFinance Special Edition

CSE’s Barrington Miller is joined by Daniel Safayeni, Director of Policy at the Ontario Chamber of Commerce to discuss the Provincial Government’s decision to end curbside pick-up and delivery of legally purchased cannabis products. Brought-in as a temporary pandemic measure, the decision to not extend (or make permanent) this policy poses risks to public safety, economic growth and employment opportunities. At this current time there is no other industry that has this measure being rescinded. Daniel also act’s as the co-chair Ontario Cannabis Policy Council (OCPC).

Learn more and connect with the OCC to show your support here: https://occ.ca/mediareleases/ontario-…

and/or contact your local MPP (Member of Provincial Parliament)

AND share this video to support the cause!

🔴 Subscribe for more great CSE insights and interviews here: https://bit.ly/CSETVSubscribe

Subscribe:  Apple Podcasts / Spotify / SoundCloud /
Stitcher / Google Podcasts / iHeart Radio / RSS